PERITONEAL NEOPLASMS
Clinical trials for PERITONEAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL NEOPLASMS trials appear
Sign up with your email to follow new studies for PERITONEAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a simple fluid change improve outcomes in major cancer surgery?
Disease control Recruiting nowThis study looks at whether adding a protein called albumin to standard IV fluids during a major cancer surgery (cytoreduction with heated chemotherapy) can lower the risk of complications after the operation. About 140 adults with abdominal cancer will be randomly assigned to re…
Matched conditions: PERITONEAL NEOPLASMS
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Could a common breast cancer drug keep ovarian cancer at bay?
Disease control Recruiting nowThis study tests whether adding letrozole, a hormone therapy used in breast cancer, to standard maintenance treatment can delay the return of ovarian cancer. About 540 women with estrogen-receptor-positive ovarian cancer who have completed initial surgery and chemotherapy will re…
Matched conditions: PERITONEAL NEOPLASMS
Phase: PHASE3 • Sponsor: Swiss GO Trial Group • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New hope for ovarian cancer: drug combo trial launches
Disease control Recruiting nowThis study tests a drug called relacorilant combined with other treatments for people with ovarian, fallopian tube, peritoneal, or endometrial cancers. About 270 participants will join to see if the combination helps slow cancer growth. The goal is to control the disease, not cur…
Matched conditions: PERITONEAL NEOPLASMS
Phase: PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
New hope for ovarian cancer: phase 3 trial of targeted drug begins
Disease control Recruiting nowThis study tests a new drug, Sofetabart Mipitecan, for people with ovarian, fallopian tube, or peritoneal cancer. Part A includes those whose cancer no longer responds to platinum chemotherapy, and Part B includes those whose cancer still responds. The goal is to see if the new d…
Matched conditions: PERITONEAL NEOPLASMS
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 08, 2026 12:02 UTC